Photodynamic Therapy With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2014
At a glance
- Drugs Temoporfin (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 14 Jan 2014 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 11 Sep 2012 Planned end date changed from 1 Jul 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 New trial record